Home Featured Page 3

Featured

Psychedelic Research Bulletin: December 2021

Nova Mentis Provides Corporate Update – 2022 Planned Catalysts

Filament Health and Cybin Therapeutics Announce Licensing Agreement

Revive Therapeutics Provides Update of Psilocybin Pharmaceutical Programs

Psychedelic Bulletin: MindMed Co-Founder Resigns from Board; Global Coalition to Reschedule Psilocybin Emerges; We Review Psychedelic Research and Trials from 2021

Levitee Labs Announces Medical Advisory Board

Red Light Holland Psilocybin Truffles, Sold in The Netherlands, Complete Second...

Entheon Biomedical Provides Update on DMT Human Trial and Announces Regulatory...

Field Trip Announces Intention to Make Applications on Behalf of Patients...

PharmaTher Announces Publication of Research Data for KETABET™

Filament Health Announces Health Canada Approval for Phase II Trial Administering...

Psychedelic Drug Policy Reform in 2021

Psychedelics 2021: A Year in Review

The McQuade Center for Strategic Research and Development and Mindset Pharma...

Awakn Life Sciences Announces Voluntary Lock-up Agreement Extension with Management, Board...

1 234...112 Page 3 of 112

EDITOR PICKS

Psychedelic Research Bulletin: December 2021

Nova Mentis Provides Corporate Update – 2022 Planned Catalysts

Filament Health and Cybin Therapeutics Announce Licensing Agreement

William Leonard Pickard participating in celebration for Sasha Shulgin’s new book...

Having Sex on DMT: What You Need to Know

PTSF49 – MDMA For Alcoholism, The Placebo Effect, and Ceremonial Magicians

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Psychedelic Research Bulletin: December 2021

Nova Mentis Provides Corporate Update – 2022 Planned Catalysts

Filament Health and Cybin Therapeutics Announce Licensing Agreement

Revive Therapeutics Provides Update of Psilocybin Pharmaceutical Programs

Psychedelic Bulletin: MindMed Co-Founder Resigns from Board; Global Coalition to Reschedule Psilocybin Emerges; We Review Psychedelic Research and Trials from 2021

Levitee Labs Announces Medical Advisory Board

Red Light Holland Psilocybin Truffles, Sold in The Netherlands, Complete Second...

Entheon Biomedical Provides Update on DMT Human Trial and Announces Regulatory...

Field Trip Announces Intention to Make Applications on Behalf of Patients...

PharmaTher Announces Publication of Research Data for KETABET™

Filament Health Announces Health Canada Approval for Phase II Trial Administering...

Psychedelic Drug Policy Reform in 2021

Psychedelics 2021: A Year in Review

The McQuade Center for Strategic Research and Development and Mindset Pharma...

Awakn Life Sciences Announces Voluntary Lock-up Agreement Extension with Management, Board...

EDITOR PICKS

Psychedelic Research Bulletin: December 2021

Nova Mentis Provides Corporate Update – 2022 Planned Catalysts

Filament Health and Cybin Therapeutics Announce Licensing Agreement

POPULAR POSTS

William Leonard Pickard participating in celebration for Sasha Shulgin’s new book...

Having Sex on DMT: What You Need to Know

PTSF49 – MDMA For Alcoholism, The Placebo Effect, and Ceremonial Magicians

POPULAR CATEGORY